Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib (GIDEON)

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: December 19, 2008
Last updated: October 14, 2016
Last verified: October 2016